BPS 321 part 2

52 terms by ldang9105 

Ready to study?
Start with Flashcards

Create a new folder

Advertisement Upgrade to remove ads

intrinsic activity

property of agonist drugs; ability to affect(alter or influence) signal activity in target cells; related to, but not identical to efficacy

inverse agonist

an agonist that produces cellular responses by decreasing constitutive signal activity

in vivo

inside the intact living organism. pertaining to the whole animal or patient

Ka

index of antagonist potency ex vivo; the average free concentration of a competitive antagonist sufficient to double the EC50 of an agonist acting on the same receptor. Ka= - log (pA2)

ligand

collective term for any drug, neurotransmitter, or hormone that binds with defined affinity to specific receptors

pA2

logarithmic form of the index of competitive antagonist potency; the molar concentration of competitive antagonist required to double the EC50 of the agonist.

partial agonist

an agonist whose intrinsic activity is not sufficient to produce maximum achievable responses in cells, organs, or tissues

pharmacology

the study of drugs, their actions, and their mechanisms of action

pharmacokinetics

the study of the processing of drugs or toxins by the body, including ADME

pD2

logarithmic form of the index of agonist potency; the molar concentration of agonist required to produce 50% of the maximal response of a cell, tissue, or organ to antagonist. pD2= - log (EC50)

PKC

protein kinase C, a signal enzyme protein that is activated by diacylglycerol

PLC

phospholipase C, enzyme associated with receptors and that catalyzes the conversion of inositol phosphates into downstream signal molecules

pharmacodynamics

the study of interactions between drugs, either agonists or antagonists, and their receptors

potency

at the cellular level, relationship between the concentration of a drug (agonist or antagonist) accessible to cellular receptors and the magnitude of the response of the cell, tissue, or organ to that drug. in vivo: relationship between the dose of a drug and the magnitude of a response. amount of drug required to produce a response of a defined magnitude

quantal response

a response to a drug that is either present or absent. refer to graded response

receptor

a molecule- mostly commonly a protein on or in a cell- that binds with defined affinity to a ligand and mediates it biologial effects

signal

a series of enzymatic reactions or molecular interactions that are functionally linked to receptors and that mediated and account for the cellular response to agonists on those receptors

stimulatory effect

an increase in the activities of the cells, tissues, or organs in response to binding of ligands to their reecptors. also called stimulatory response

stimulatory receptor

a receptor whose activation ultimately results in an acceleration or intensification of the activities of the cell, tissue, or organ

toxicology

the study of toxins, their actions, and their mechanism of action

toxin

any chemical substance that, in sufficient quantities, exerts harmful effects on biological systems.

Adenylate Cyclase

A signal enzyme associated with GPCRs that converts ATP to cyclic adenosine monophosphate (cAMP), a downstream signal molecule

Affinity

Relationship between the free concentration of a ligand in the vicinity of its receptors and the fraction of the total number of accessible receptors that are bound to the ligand. Both agonists and antagonists have affinity for theirs receptors.

Agonist

A ligand that activates a receptor upon binding to it. Agonists possess the property of intrinsic activity,

Agonist potency

At the cellular level, the relationship between the concentration of an agonist in the vicinity of its receptors and the magnitude of the ensuing response of the cell, tissue, or organ; at the whole-animal or patient level, the relationship between the dose of an agonist drug and the magnitude of the observable response.

Constitutive signal

Basal signal activity in a cell that is present even in the absence of receptor activation by an agonist

Drug

Any non-nutrient chemical substance that, in sufficient quantities, alters the activities of biological systems.

Drug Concentration

Amount of a drug dissolved in blood or other solutions in patients or whole animals, or in perfusing or bathing solutions in isolated cells or organs (expressed in units such as moles per liter [M] or micrograms per deciliter [ug/dL]).

Antagonist

A ligand that binds to a receptor but does not activate it. lack intrinsic activity.

Antagonist potency

At the cellular level, the relationship between the concentration of an antagonist in the vicinity of its receptors and the magnitude of the inhibition of agonist effects on those receptors; at the whole animal or patient level, the relationship between the dose of an antagonist drug and the magnitude of the observable response

Drug Dose

Amount of a drug administered to a patient or whole animal (expressed in mg, mg/Kg of body weight, or square meters of surface area, etc.)

EC_50_

Index of agonist potency ex vivo. It is the antilog of the pD_2_

ED_50_

Index of potency in vivo (in whole animals or patients) of an agonist or antagonist drug.

Ex vivo

outside the body or isolated from the body, usually isolated cells, tissues, or organs.

Effect (response)

Specific and measurable (observable) change in cellular signal or observable response to the agonist.

Effector

Protein or other macromolecule that is an ultimate target of a signal pathway

Endogenous

originating from and acting inside the body (e.g. hormones and neurotransmitters)

Exogenous

Produced, or administered from, outside the body. all drugs, even hormones or neurotransmitters used as drugs are exogenous.

Full agonist

an agonist whose intrinsic activity is sufficient to produce maximum achievable responses in cells, organs, or whole animals or patients.

GPCR

G protein-coupled receptors; a broad category of receptors that are associated with regulatory complexs called G proteins because they bind to GTP and GDP

Graded Response

a response to a drug that is, more or less, or a continuum, e.g. changes in urine production or blood pressure. See quantal response.

Inhibitory effect

A decrease in activities of cells, tissues, or organs in response to binding of ligands to their receptors; also called inhibitory responses.

Inhibitory receptors

A receptors whose activation decreases the activities of the cell, tissue, or organ.

signaling bias

one receptor has different isoforms that will create different responses

functional ligand selectivity

two ligands of similar structure produce diff activities

signal crosstalk

one GPCR signaling pathway will effect another pathway

receptor desensitization

same number of receptors, receptors less sensitive

receptor down regulation

different number of receptors on surface

tachyphylaxis

rapid loss of intrinsic activity (secs/mins)

longer term pharmacodynamic tolerance

delayed loss of activity (hrs/days)

super sensitivity/ receptor upregulation

when antagonist causes more receptors to be on the cell surface because agonists cant downregulate/desensitize them so sudden discontinuation will create an influx of agonists to create a heightened response

cumulative dose response curve

concentration is added on top of existing concentration

Please allow access to your computer’s microphone to use Voice Recording.

Having trouble? Click here for help.

We can’t access your microphone!

Click the icon above to update your browser permissions above and try again

Example:

Reload the page to try again!

Reload

Press Cmd-0 to reset your zoom

Press Ctrl-0 to reset your zoom

It looks like your browser might be zoomed in or out. Your browser needs to be zoomed to a normal size to record audio.

Please upgrade Flash or install Chrome
to use Voice Recording.

For more help, see our troubleshooting page.

Your microphone is muted

For help fixing this issue, see this FAQ.

Star this term

You can study starred terms together

NEW! Voice Recording

Create Set